(PM) Philip Morris International - Ratings and Ratios
Cigarettes, Heat-Not-Burn, Vapor, Oral Nicotine, Accessories
PM EPS (Earnings per Share)
PM Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.5% |
| Value at Risk 5%th | 38.6% |
| Relative Tail Risk | -4.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.94 |
| Alpha | 24.54 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.518 |
| Beta | 0.109 |
| Beta Downside | 0.240 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.64% |
| Mean DD | 5.43% |
| Median DD | 5.06% |
Description: PM Philip Morris International September 24, 2025
Philip Morris International Inc. (NYSE: PM) is a U.S.–based tobacco company that manufactures and sells both traditional cigarettes and a portfolio of smoke-free products-including heat-not-burn (IQOS), vapor (IQOS Vapor), and oral nicotine (ZYN) offerings-along with consumer accessories such as lighters and matches. The firm also markets wellness and healthcare items. Incorporated in 1987, its corporate headquarters are in Stamford, Connecticut.
Key recent metrics: FY 2023 net revenue reached approximately $31.4 billion, with smoke-free products accounting for roughly 30 % of total sales and growing at a double-digit annual rate. The IQOS platform now operates in over 70 countries, delivering a compound annual growth rate (CAGR) of about 15 % since launch. A primary sector driver is the global decline in cigarette consumption-down ~2 % YoY-paired with tightening regulatory environments that favor reduced-risk products, which together pressure legacy tobacco margins while creating upside for diversified nicotine portfolios.
For a deeper, data-driven view of PM’s valuation dynamics and scenario analysis, you may find the research tools on ValueRay worth exploring.
PM Stock Overview
| Market Cap in USD | 224,670m |
| Sub-Industry | Tobacco |
| IPO / Inception | 2008-03-17 |
| Return 12m vs S&P 500 | 9.73% |
| Analyst Rating | 4.06 of 5 |
PM Dividends
| Dividend Yield | 3.55% |
| Yield on Cost 5y | 8.99% |
| Yield CAGR 5y | 2.83% |
| Payout Consistency | 99.1% |
| Payout Ratio | 74.7% |
PM Growth Ratios
| CAGR 3y | 23.22% |
| CAGR/Max DD Calmar Ratio | 1.12 |
| CAGR/Mean DD Pain Ratio | 4.27 |
| Current Volume | 3529.3k |
| Average Volume | 6200.3k |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (8.61b TTM) > 0 and > 6% of Revenue (6% = 2.40b TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 0.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 36.17% (prev -6.91%; Δ 43.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 11.53b > Net Income 8.61b (YES >=105%, WARN >=100%) |
| Net Debt (46.05b) to EBITDA (17.68b) ratio: 2.60 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.56b) change vs 12m ago 0.13% (target <= -2.0% for YES) |
| Gross Margin 66.27% (prev 64.18%; Δ 2.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 59.63% (prev 55.64%; Δ 3.99pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.18 (EBITDA TTM 17.68b / Interest Expense TTM 1.92b) >= 6 (WARN >= 3) |
Altman Z'' 2.85
| (A) 0.22 = (Total Current Assets 22.66b - Total Current Liabilities 8.22b) / Total Assets 67.06b |
| (B) -0.02 = Retained Earnings (Balance) -1.56b / Total Assets 67.06b |
| (C) 0.23 = EBIT TTM 15.69b / Avg Total Assets 66.98b |
| (D) -0.06 = Book Value of Equity -4.68b / Total Liabilities 76.05b |
| Total Rating: 2.85 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.14
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 3.74% = 1.87 |
| 3. FCF Margin 25.35% = 6.34 |
| 4. Debt/Equity -4.59 = -2.50 |
| 5. Debt/Ebitda 2.60 = -1.14 |
| 6. ROIC - WACC (= 29.44)% = 12.50 |
| 7. RoE -75.66% = -2.50 |
| 8. Rev. Trend 89.36% = 6.70 |
| 9. EPS Trend 77.53% = 3.88 |
What is the price of PM shares?
Over the past week, the price has changed by +1.33%, over one month by -2.29%, over three months by -5.07% and over the past year by +25.77%.
Is Philip Morris International a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PM is around 170.07 USD . This means that PM is currently overvalued and has a potential downside of 9.42%.
Is PM a buy, sell or hold?
- Strong Buy: 7
- Buy: 5
- Hold: 4
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the PM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 186.7 | 20.1% |
| Analysts Target Price | 186.7 | 20.1% |
| ValueRay Target Price | 184.2 | 18.5% |
PM Fundamental Data Overview November 04, 2025
P/E Trailing = 20.5892
P/E Forward = 18.8324
P/S = 5.6179
P/EG = 1.0125
Beta = 0.479
Revenue TTM = 39.94b USD
EBIT TTM = 15.69b USD
EBITDA TTM = 17.68b USD
Long Term Debt = 42.17b USD (from longTermDebt, last fiscal year)
Short Term Debt = 2.74b USD (from shortTermDebt, last quarter)
Debt = 50.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 46.05b USD (from netDebt column, last quarter)
Enterprise Value = 270.71b USD (224.67b + Debt 50.08b - CCE 4.04b)
Interest Coverage Ratio = 8.18 (Ebit TTM 15.69b / Interest Expense TTM 1.92b)
FCF Yield = 3.74% (FCF TTM 10.12b / Enterprise Value 270.71b)
FCF Margin = 25.35% (FCF TTM 10.12b / Revenue TTM 39.94b)
Net Margin = 21.56% (Net Income TTM 8.61b / Revenue TTM 39.94b)
Gross Margin = 66.27% ((Revenue TTM 39.94b - Cost of Revenue TTM 13.47b) / Revenue TTM)
Gross Margin QoQ = 67.85% (prev 67.66%)
Tobins Q-Ratio = 4.04 (Enterprise Value 270.71b / Total Assets 67.06b)
Interest Expense / Debt = 0.46% (Interest Expense 230.0m / Debt 50.08b)
Taxrate = 17.21% (751.0m / 4.36b)
NOPAT = 12.99b (EBIT 15.69b * (1 - 17.21%))
Current Ratio = 2.76 (Total Current Assets 22.66b / Total Current Liabilities 8.22b)
Debt / Equity = -4.59 (negative equity) (Debt 50.08b / totalStockholderEquity, last quarter -10.91b)
Debt / EBITDA = 2.60 (Net Debt 46.05b / EBITDA 17.68b)
Debt / FCF = 4.55 (Net Debt 46.05b / FCF TTM 10.12b)
Total Stockholder Equity = -11.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.84% (Net Income 8.61b / Total Assets 67.06b)
RoE = -75.66% (negative equity) (Net Income TTM 8.61b / Total Stockholder Equity -11.38b)
RoCE = 50.97% (EBIT 15.69b / Capital Employed (Equity -11.38b + L.T.Debt 42.17b))
RoIC = 34.76% (NOPAT 12.99b / Invested Capital 37.37b)
WACC = 5.32% (E(224.67b)/V(274.75b) * Re(6.42%) + D(50.08b)/V(274.75b) * Rd(0.46%) * (1-Tc(0.17)))
Discount Rate = 6.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.13%
[DCF Debug] Terminal Value 77.70% ; FCFE base≈10.09b ; Y1≈9.70b ; Y5≈9.51b
Fair Price DCF = 108.9 (DCF Value 169.53b / Shares Outstanding 1.56b; 5y FCF grow -5.18% → 3.0% )
EPS Correlation: 77.53 | EPS CAGR: 18.95% | SUE: 2.38 | # QB: 1
Revenue Correlation: 89.36 | Revenue CAGR: 10.94% | SUE: 1.05 | # QB: 1
Additional Sources for PM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle